National Institute of Allergy and Infectious Diseases; Notice of Meetings, 68266-68267 [2021-26134]
Download as PDF
<![CDATA[
68266
Federal Register / Vol. 86, No. 228 / Wednesday, December 1, 2021 / Notices
• General Records Schedule (GRS)
2.2 Employee Management Records,
Item 080, supervisor’s personnel files
(these include employee medical
documents until replaced by the
agency’s accommodation decision, and
exclude records that become part of a
grievance file, an appeal or
discrimination complaint file, a
performance-based reduction-in-grade
or removal action, or an adverse action,
which are governed by GRS 2.3
Employee Relations Records): Review
annually and destroy superseded
documents. Destroy remaining
documents one year after employee
separation or transfer.
• GRS 2.3 Employee Relations
Records, Item 020, reasonable
accommodation case files: Destroy three
years after employee separation from the
agency or after all appeals are
concluded, whichever is later, but
longer retention is authorized if
required for business use.
Accommodation records about federal
contractors are retained and disposed of
in accordance with the following
disposition authority:
• GRS 2.3 Employee Relations
Records, Item 120, records documenting
contractor compliance with EEO
regulations: Destroy when 7 years old,
but longer retention is authorized if
required for business use.
Accommodation records about HHS
visitors who are neither federal
employees nor federal contractors are
currently unscheduled and will be
retained indefinitely until authorized
for disposition under a schedule
approved by the National Archives and
Records Administration.
lotter on DSK11XQN23PROD with NOTICES1
ADMINISTRATIVE, TECHNICAL, AND PHYSICAL
SAFEGUARDS:
Safeguards conform to the HHS
Information Security and Privacy
Program, https://www.hhs.gov/ocio/
securityprivacy/, including
the HHS Information Security and
Privacy Policy (IS2P), which ensures
that information is safeguarded in
accordance with applicable federal
laws, rules, and policies, including: 44
U.S.C. 3541 through 3549 and 3551
through 3558; all pertinent National
Institutes of Standards and Technology
(NIST) publications; and OMB Circular
A–130, Managing Information as a
Strategic Resource, 81 FR 49689 (July
28, 2016).
Records are protected from
unauthorized access through
appropriate administrative, physical,
and technical safeguards. These
safeguards include protecting the
facilities where records are received and
electronically stored with security
VerDate Sep<11>2014
17:08 Nov 30, 2021
Jkt 256001
guards, identification badges, and
cameras; securing any hard copies in
locked file cabinets, file rooms or offices
during off-duty hours; requiring
contractors to maintain appropriate
safeguards and to comply with the
Privacy Act with respect to the records;
limiting authorized users’ access to
electronic records based on role and
either two-factor authentication or
password protection; requiring
passwords to be complex and to be
changed frequently; using a secured
operating system protected by
encryption, firewalls, and intrusion
detection systems; maintaining an
activity log of users’ access; requiring
encryption for any records stored or
accessed on removable media; training
personnel in Privacy Act and
information security requirements; and
reviewing security controls on an
ongoing basis.
To control and limit access, use, and
disclosure of the records appropriately,
HHS may maintain disability-based
accommodation records in or with other
confidential medical files about the
same individual, or otherwise separately
from other types of records about the
same individual, to the extent possible.
Likewise, to the extent possible, HHS
maintains religious accommodation
records about an individual separately
from other types of records about the
individual.
Individuals may request access to
records about them in this system of
records by submitting a written access
request to the System Manager
identified in the ‘‘System Manager’’
section of this SORN. The request must
contain the requester’s full name, home
or work address, date of birth, signature,
and assigned case identification number
(if any) and must identify the employing
or hiring component pertinent to the
request. To verify the requester’s
identity, the signature must be notarized
or the request must include the
requester’s written certification that the
requester is the individual who the
requester claims to be and that the
requester understands that the knowing
and willful request for or acquisition of
a record pertaining to an individual
under false pretenses is a criminal
offense subject to a fine of up to $5,000.
To access the records in person, the
requester should make an appointment,
and may be accompanied by a person of
the requester’s choosing if the requester
provides written authorization for
agency personnel to discuss the records
in that person’s presensce. An
individual may also request an
Frm 00054
Fmt 4703
Sfmt 4703
CONTESTING RECORD PROCEDURES:
Individuals may seek to amend
records about them in this system of
records by submitting an amendment
request to the System Manager
identified in the ‘‘System Manager’’
section of this SORN, containing the
same information required for an access
request. The request must include
verification of the requester’s identity in
the same manner required for an access
request; must reasonably identify the
record and specify the information
contested, the corrective action sought,
and the reasons for requesting the
correction; and should include
supporting information to show how the
record is not accurate, complete, timely,
or relevant.
NOTIFICATION PROCEDURES:
Individuals who wish to know if this
system of records contains records about
them should submit a notification
request to the System Manager
identified in the ‘‘System Manager’’
section of this SORN. The request must
contain the same information required
for an access request and must include
verification of the requester’s identity in
the same manner required for an access
request.
EXEMPTIONS PROMULGATED FOR THE SYSTEM:
None.
RECORD ACCESS PROCEDURES:
PO 00000
accounting of disclosures that have been
made of the records, if any.
HISTORY:
None.
[FR Doc. 2021–26090 Filed 11–30–21; 8:45 am]
BILLING CODE 4151–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meeting will be open to the
public. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
E:\FR\FM\01DEN1.SGM
01DEN1
Federal Register / Vol. 86, No. 228 / Wednesday, December 1, 2021 / Notices
lotter on DSK11XQN23PROD with NOTICES1
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: January 31, 2022.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immune Deficiency Syndrome
Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
17:08 Nov 30, 2021
Jkt 256001
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Immunology and Transplantation
Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 4F50, Bethesda, MD
20892, 301–496–7291,
fentonm@niaid.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaid.nih.gov/about/advisory-council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 24, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–26134 Filed 11–30–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
68267
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Vision and Low Vision Technologies.
Date: December 13, 2021.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barbara Susanne Mallon,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, mallonb@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Drug Discovery in Neuroscience.
Date: December 16, 2021.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aurea D. De Sousa, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
Bethesda, MD 20892, 301–827–6829,
aurea.desousa@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\01DEN1.SGM
01DEN1
]]>Agencies
[Federal Register Volume 86, Number 228 (Wednesday, December 1, 2021)]
[Notices]
[Pages 68266-68267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meeting will be open to the public. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov). Individuals who need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
[[Page 68267]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: January 31, 2022.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Acquired Immune Deficiency Syndrome Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Immunology and Transplantation Subcommittee.
Date: January 31, 2022.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 4G30,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.niaid.nih.gov/about/advisory-council, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 24, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-26134 Filed 11-30-21; 8:45 am]
BILLING CODE 4140-01-P
